BSX EBITDA | BOSTON SCIENTIFIC CORPORATION

BOSTON SCIENTIFIC CORPORATION (BSX) EBITDA

2026-06-30: Basis Reported; EBITDA $1.53B*; Operating income $1.18B; Depreciation and amortization $355.00M*.
2026-03-31: Basis Reported; EBITDA $1.45B; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $1.19B; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $1.39B*; Operating income $1.05B; Depreciation and amortization $342.00M*.

Complete source-backed ebitda history.

Available history: 2009-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$1.53B*	$1.18B	$355.00M*	$5.44B	28.17%*	$195.00M*	$1.47B*	$1.59B	(m)	$1.80B	$155.00M
2026-03-31	Reported	$1.45B	(m)	(m)	(m)	27.91%	$177.00M	$348.00M	$1.59B	(m)	$1.78B	-$176.00M
2025-12-31	Reported	$1.19B	(m)	(m)	(m)	22.51%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$1.39B*	$1.05B	$342.00M*	$5.07B	27.44%*	$181.00M*	$1.34B*	$1.52B	(m)	$1.74B	$183.00M
2025-06-30	Reported	$1.16B*	$819.00M	$336.00M*	$5.06B	22.82%*	$157.00M*	$1.29B*	$1.64B	(m)	$1.72B	$146.00M
2025-03-31	Reported	$1.25B	(m)	(m)	(m)	26.72%	$187.00M	$541.00M	$1.45B	(m)	$1.60B	$133.00M
2024-12-31	Reported	$1.02B	(m)	(m)	(m)	22.43%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$1.04B*	$733.00M	$306.00M*	$4.21B	24.69%*	$179.00M*	$1.00B*	$1.31B	(m)	$1.56B	$200.00M
2024-06-30	Reported	$831.00M*	$520.00M	$311.00M*	$4.12B	20.17%*	$155.00M*	$813.00M*	$1.27B	(m)	$1.45B	$98.00M
2024-03-31	Reported	$979M	(m)	(m)	(m)	25.39%	$179.00M	$164.00M	$1.21B	(m)	$1.36B	$115.00M
2023-12-31	Reported	$897M	(m)	(m)	(m)	24.08%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$993.00M*	$693.00M	$300.00M*	$3.53B	28.15%*	$190.00M*	$698.00M*	$1.10B	(m)	$1.24B	$105.00M
2023-06-30	Reported	$812.00M*	$514.00M	$298.00M*	$3.60B	22.56%*	$143.00M*	$658.00M*	$1.06B	(m)	$1.35B	$156.00M
2023-03-31	Reported	$837M	(m)	(m)	(m)	24.70%	$111.00M	$190.00M	$1.04B	(m)	$1.22B	$131.00M
2022-12-31	Reported	$696M	(m)	(m)	(m)	21.47%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	$642.00M*	$358.00M	$284.00M*	$3.17B	20.25%*	$150.00M*	$470.00M*	$979.00M	(m)	$1.13B	$57.00M
2022-06-30	Reported	$707.00M*	$423.00M	$284.00M*	$3.24B	21.79%*	$105.00M*	$307.00M*	$1.01B	(m)	$1.17B	$85.00M
2022-03-31	Reported	$740M	(m)	(m)	(m)	24.45%	$121.00M	-$58.00M	$955.00M	(m)	$1.06B	$45.00M
2021-12-31	Reported	$470M	(m)	(m)	(m)	15.03%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	$659.00M*	$387.00M	$272.00M*	$2.93B	22.48%*	$107.00M*	$465.00M*	$900.00M	(m)	$1.07B	$64.00M
2021-06-30	Reported	$525.00M*	$262.00M	$263.00M*	$3.08B	17.06%*	$106.00M*	$643.00M*	$945.00M	(m)	$1.12B	-$37.00M
2021-03-31	Reported	$638M	(m)	(m)	(m)	23.18%	$75.00M	$284.00M	$894.00M	(m)	$1.02B	-$16.00M
2020-12-31	Reported	$339M	(m)	(m)	(m)	12.51%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	$77.00M*	-$205.00M	$282.00M*	$2.66B	2.90%*	$49.00M*	$643.00M*	$869.00M	(m)	$984.00M	-$72.00M
2020-06-30	Reported	$204.00M*	-$71.00M	$275.00M*	$2.00B	10.18%*	$68.00M*	$269.00M*	$791.00M	(m)	$798.00M	-$33.00M
2020-03-31	Reported	$423M	(m)	(m)	(m)	16.63%	$100.00M	-$77.00M	$806.00M	(m)	$978.00M	$12.00M
2019-09-30	Reported	(m)	$383.00M	(m)	$2.71B	(m)	$121.00M*	$502.00M*	$777.00M	(m)	$1.01B	-$35.00M
2019-06-30	Reported	(m)	$384.00M	(m)	$2.63B	(m)	$91.00M*	$292.00M*	$758.00M	(m)	$968.00M	-$9.00M
2019-03-31	Reported	(m)	$541.00M	(m)	$2.49B	(m)	$63.00M	$350.00M	$730.00M	(m)	$869.00M	$33.00M
2018-09-30	Reported	(m)	$388.00M	(m)	$2.39B	(m)	$76.00M*	$501.00M*	$672.00M	(m)	$870.00M	$24.00M
2018-06-30	Reported	(m)	$392.00M	(m)	$2.49B	(m)	$74.00M*	-$403.00M*	$739.00M	(m)	$886.00M	-$209.00M
2018-03-31	Reported	(m)	$407.00M	(m)	$2.38B	(m)	$60.00M	$193.00M	$672.00M	(m)	$860.00M	$26.00M
2017-09-30	Reported	(m)	$377.00M	(m)	$2.22B	(m)	$60.00M*	$452.00M*	$637.00M	(m)	$800.00M	$26.00M
2017-06-30	Reported	(m)	$225.00M	(m)	$2.26B	(m)	$68.00M*	$297.00M*	$632.00M	(m)	$815.00M	-$55.00M
2017-03-31	Reported	(m)	$364.00M	(m)	(m)	(m)	$112.00M	-$7.00M	$650.00M	(m)	$794.00M	$15.00M
2016-09-30	Reported	(m)	$348.00M	(m)	(m)	(m)	$71.00M*	-$31.00M*	$594.00M	(m)	$772.00M	$29.00M
2016-06-30	Reported	(m)	-$334.00M	(m)	(m)	(m)	$78.00M*	$421.00M*	$639.00M	(m)	$779.00M	-$190.00M
2016-03-31	Reported	(m)	$293.00M	(m)	(m)	(m)	$60.00M	$116.00M	$573.00M	(m)	$716.00M	$26.00M
2015-09-30	Reported	(m)	-$299.00M	(m)	(m)	(m)	$70.00M*	$408.00M*	$539.00M	(m)	$729.00M	-$169.00M
2015-06-30	Reported	(m)	$219.00M	(m)	(m)	(m)	$46.00M*	$60.00M*	$540.00M	(m)	$700.00M	$3.00M
2015-03-31	Reported	(m)	$24.00M	(m)	(m)	(m)	$46.00M	-$197.00M	$520.00M	(m)	$668.00M	-$50.00M
2014-09-30	Reported	(m)	$64.00M	(m)	(m)	(m)	$56.00M*	$346.00M*	$550.00M	(m)	$741.00M	-$40.00M
2014-06-30	Reported	(m)	-$69.00M	(m)	(m)	(m)	$65.00M*	$285.00M*	$563.00M	(m)	$743.00M	-$108.00M
2014-03-31	Reported	(m)	$197.00M	(m)	(m)	(m)	$59.00M	$198.00M	$537.00M	(m)	$666.00M	$13.00M
2013-09-30	Reported	(m)	$103.00M	(m)	(m)	(m)	$57.00M*	$251.00M*	$510.00M	(m)	$658.00M	-$35.00M
2013-06-30	Reported	(m)	$220.00M	(m)	(m)	(m)	$51.00M*	$397.00M*	$530.00M	(m)	$661.00M	$22.00M
2013-03-31	Reported	(m)	-$330.00M	(m)	(m)	(m)	$53.00M	$187.00M	$578.00M	(m)	$631.00M	-$40.00M
2012-09-30	Reported	(m)	-$594.00M	(m)	(m)	(m)	$46.00M*	$272.00M*	$558.00M	(m)	$589.00M	$1.00M
2012-06-30	Reported	(m)	-$3.59B	(m)	(m)	(m)	$52.00M*	$407.00M*	$578.00M	(m)	$648.00M	-$40.00M
2012-03-31	Reported	(m)	$196.00M	(m)	(m)	(m)	$66.00M	$212.00M	$631.00M	(m)	$659.00M	$10.00M
2011-09-30	Reported	(m)	$174.00M	(m)	(m)	(m)	$69.00M*	$366.00M*	$680.00M	(m)	$629.00M	-$31.00M
2011-06-30	Reported	(m)	$237.00M	(m)	(m)	(m)	$83.00M*	$390.00M*	$688.00M	(m)	$642.00M	$12.00M
2011-03-31	Reported	(m)	$322.00M	(m)	(m)	(m)	$69.00M	-$97.00M	$631.00M	(m)	$596.00M	$227.00M
2010-12-31	Reported	(m)	$349.00M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	(m)	$251.00M	(m)	(m)	(m)	$78.00M*	-$126.00M*	$623.00M	(m)	$634.00M	-$27.00M
2010-06-30	Reported	(m)	$231.00M	(m)	(m)	(m)	$61.00M*	$286.00M*	$654.00M	(m)	$634.00M	$21.00M
2010-03-31	Reported	(m)	-$1.49B	(m)	(m)	(m)	$70.00M	-$284.00M	$663.00M	(m)	$628.00M	$14.00M
2009-12-31	Reported	(m)	-$1.23B	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2009-09-30	Reported	(m)	$51.00M	(m)	(m)	(m)	$91.00M*	$484.00M*	$629.00M	(m)	$665.00M	$50.00M
2009-06-30	Reported	(m)	$275.00M	(m)	(m)	(m)	$74.00M*	$419.00M*	$630.00M	(m)	$671.00M	$22.00M
2009-03-31	Reported	(m)	$11.00M	(m)	(m)	(m)	$60.00M	$261.00M	$607.00M	(m)	$651.00M	-$84.00M
2008-09-30	Reported	(m)	$28.00M	(m)	(m)	(m)	$72.00M*	$638.00M*	$655.00M	(m)	$610.00M	-$6.00M
2008-06-30	Reported	(m)	$303.00M	(m)	(m)	(m)	(m)	(m)	$604.00M	(m)	$655.00M	$2.00M

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$4.98B	(m)	(m)	(m)	24.81%	$876.00M	$4.53B	$6.22B	(m)	$6.89B	$493.00M
2024-12-31	Reported	$3.87B	(m)	(m)	(m)	23.12%	$790.00M	$3.44B	$5.26B	(m)	$5.98B	$436.00M
2023-12-31	Reported	$3.54B	(m)	(m)	(m)	24.85%	$711.00M	$2.50B	$4.34B	(m)	$5.19B	$393.00M
2022-12-31	Reported	$2.79B	(m)	(m)	(m)	21.96%	$588.00M	$1.53B	$3.96B	(m)	$4.52B	$443.00M
2021-12-31	Reported	$2.29B	(m)	(m)	(m)	19.28%	$554.00M	$1.87B	$3.71B	(m)	$4.36B	$36.00M
2020-12-31	Reported	$1.04B	(m)	(m)	(m)	10.52%	$376.00M	$1.51B	$3.46B	(m)	$3.79B	$2.00M
2019-12-31	Reported	$2.53B	(m)	(m)	(m)	23.56%	$461.00M	$1.84B	$3.12B	(m)	$3.94B	-$4.01B
2018-12-31	Reported	$2.4B	(m)	(m)	(m)	24.43%	$316.00M	$310.00M	$2.81B	(m)	$3.57B	-$249.00M
2017-12-31	Reported	$2.13B	(m)	(m)	(m)	23.53%	$319.00M	$1.43B	$2.59B	(m)	$3.29B	$828.00M
2016-12-31	Reported	$1.26B	(m)	(m)	(m)	15.05%	$376.00M	$1.18B	$2.42B	(m)	$3.10B	-$170.00M
2015-12-31	Reported	$486M	(m)	(m)	(m)	6.50%	$247.00M	$691.00M	$2.17B	(m)	$2.87B	-$411.00M
2014-12-31	Reported	$424M	(m)	(m)	(m)	5.75%	$259.00M	$1.27B	$2.21B	(m)	$2.90B	-$390.00M
2013-12-31	Reported	$809M	(m)	(m)	(m)	11.33%	$245.00M	$1.11B	$2.17B	(m)	$2.67B	-$102.00M
2012-12-31	Reported	-$3.19B	(m)	(m)	(m)	-43.94%	$226.00M	$1.28B	$2.35B	(m)	$2.54B	-$39.00M
2011-12-31	Reported	$1.62B	(m)	(m)	(m)	21.27%	$304.00M	$1.01B	$2.66B	(m)	$2.49B	$201.00M
2011-09-30	Rolling	(m)	$1.08B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-06-30	Rolling	(m)	$1.16B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-03-31	Rolling	(m)	$1.15B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-12-31	Reported	$160M	(m)	(m)	(m)	2.05%	$272.00M	$325.00M	$2.60B	(m)	$2.58B	$2.00M
2010-12-31	Rolling	(m)	-$655.00M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Rolling	(m)	-$2.23B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-06-30	Rolling	(m)	-$2.44B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-03-31	Rolling	(m)	-$2.39B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2009-12-31	Reported	-$60M	(m)	(m)	(m)	-0.73%	$312.00M	$835.00M	$2.58B	(m)	$2.63B	-$283.00M
2009-12-31	Rolling	(m)	-$894.00M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2008-12-31	Reported	(m)	-$1.50B	(m)	(m)	(m)	$362.00M	$1.22B	$2.47B	(m)	$2.59B	$5.00M
2007-12-31	Reported	(m)	-$14.00M	(m)	(m)	(m)	$363.00M	$934.00M	$2.34B	(m)	$2.91B	-$74.00M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
BECTON DICKINSON & CO (BDX)	United States	$48.834B	43.79
3M CO (MMM)	United States	$86.404B	27.87
DEXCOM INC (DXCM)	United States	$33.004B	25.42
WEST PHARMACEUTICAL SERVICES INC (WST)	United States	$26.288B	43.14
STRYKER CORP (SYK)	United States	$103.511B	32.39
Solventum Corp (SOLV)	United States	$15.085B	9.16
Penumbra Inc (PEN)	United States	$12.596B	77.33
BAXTER INTERNATIONAL INC (BAX)	United States	$12.139B	-10.35
GLOBUS MEDICAL INC (GMED)	United States	$9.977B	20.03
INSULET CORP (PODD)	United States	$9.420B	28.12